BYAKANGELICIN (b)
BYAKANGELICINa main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitorand is effective for the treatment of sugar cataracts and diabetic neuropathy and hence might be useful as a lead compound for the development of new type drugs for clinical use.
Product Specifications
CAS Number
482-25-7
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 50 mg/mL (149.56 mM)
Smiles
COc1c2ccoc2c (OC[C@@H] (O) C (C) (C) O) c2oc (=O) ccc12
Molecular Formula
C17H18O7
Molecular Weight
334.32
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
7H-Furo (32-g) (1) benzopyran-7-one 9- (23-dihydroxy-3-methylbutoxy) -4-methoxy- (R) -
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![2-Amino-3-[2- (tert-butoxy) -2-oxoethoxy]propanoic acid](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
orb3181703-01 10 mg
2-Amino-3-[2- (tert-butoxy) -2-oxoethoxy]propanoic acid
Sign In for Pricing
View Details orb3181703-02 50 mg
2-Amino-3-[2- (tert-butoxy) -2-oxoethoxy]propanoic acid
Sign In for Pricing
View Details 
MBS9320189-01 48 Well
Human Metastasis-associated protein MTA1, MTA1 ELISA Kit
Sign In for Pricing
View Details MBS9320189-02 96 Well
Human Metastasis-associated protein MTA1, MTA1 ELISA Kit
Sign In for Pricing
View Details